A research team of the Institute of Virology of the University of Veterinary Medicine Vienna has achieved a major breakthrough in exploring the rabies virus: for the first time, researchers were able to exactly depict the ...
Jul 29, 2019
0
25
Scientists have learned how to observe the processes of oncolytic viruses in cancer cells in real time. For the first time ever, a group of scientists from NUST MISIS and the University of Calgary (Canada) has applied intravital ...
Sep 10, 2018
0
6
The experimental Ebola vaccine dubbed rVSV-ZEBOV has shown promising signs that it can contain the spread of the prolific killer virus.
May 18, 2018
0
2
An organic chemical compound shows effective antiviral activity against Ebola virus and several other viruses, according to a study led by Georgia State University.
Mar 28, 2018
0
3
The latest outbreaks of emerging, dangerous pathogens, such as Ebola, MERS-CoV or Zika, emphasise the importance of the rapid development of effective vaccines. However, being able to predict the efficacy of new vaccines ...
Sep 07, 2017
0
0
A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants 6 months after immunization. ...
Jun 19, 2017
0
105
Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect. This is one of the results of a new study from a large European ...
Apr 26, 2017
0
0
Viruses and their hosts are in a eternal game of one-upmanship. If a host cell evolves a way to stop a virus from spreading, the virus will look for a new path. And so on and so forth.
Jan 11, 2017
0
20
Forty years after emerging in what is today the Democratic Republic of Congo, the Ebola virus may finally have met its match in a vaccine which could be "up to 100 percent effective", according to its makers.
Dec 23, 2016
0
0
Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 vaccinated participants in the Phase 2 randomized, placebo-controlled clinical trial ...
Feb 24, 2016
0
0
